
View larger version (19K):
[in a new window]
|
Fig. 6. Evidence for binding of Wnt4 to the CRD of CPZ. (A) Schematic illustration
of the constructs tested in co-immunoprecipitation assays. The domains of the
proteins are indicated (for abbreviations see below). The CPZ constructs
bearing the point mutation of Glu477 to Gln477
(CPZmyc/E477Q and CPZ CRD/myc/E477Q) are not
depicted. (B) Western blots of lysates of cells co-transfected with
Wnt4HA and the constructs depicted in A detected with an anti-myc
antibody. All proteins were expressed and had the expected molecular mass (see
A). (C) A western blot of proteins of the lysates in B after co-precipitation
with Wnt4HA, detected with an anti-myc antibody.
sFRP-2myc (positive control), CPZmyc,
CPZmyc/E477Q and CPZ CP/myc co-precipitated with
Wnt4HA. In contrast, the CRD deletion mutants,
CPZ CRD/myc and CPZ CRD/myc/E477Q, did not
bind to Wnt4HA. Note that the two bands at 25 kDa and 50 kDa in C
are the immunoglobulin heavy and light chain of the primary antibody, which
are also detected by the secondary antibody which is derived from the same
species as the primary antibody. Since the sizes of these bands differ from
those of the tested proteins, they do not interfere with detection of these
proteins, but serve as a loading control. CP, carboxypeptidase domain; CRD,
cysteine-rich-domain; Ni, netrin-like domain; SP, signal peptide.
|